Nuveen Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $8.22M | Sell |
146,903
-972
| -0.7% | -$54.4K | ﹤0.01% | 1694 |
|
|
2024
Q3 | $7.75M | Sell |
147,875
-1,244
| -0.8% | -$65.2K | ﹤0.01% | 1760 |
|
|
2024
Q2 | $6.12M | Buy |
149,119
+6,384
| +4% | +$262K | ﹤0.01% | 1844 |
|
|
2024
Q1 | $6.18M | Sell |
142,735
-934
| -0.7% | -$40.5K | ﹤0.01% | 1864 |
|
|
2023
Q4 | $6.6M | Buy |
143,669
+2,084
| +1% | +$95.8K | ﹤0.01% | 1817 |
|
|
2023
Q3 | $3.25M | Sell |
141,585
-56,858
| -29% | -$1.3M | ﹤0.01% | 2076 |
|
|
2023
Q2 | $3.27M | Buy |
198,443
+149,039
| +302% | +$2.46M | ﹤0.01% | 2113 |
|
|
2023
Q1 | $881K | Buy |
49,404
+1,913
| +4% | +$34.1K | ﹤0.01% | 2651 |
|
|
2022
Q4 | $1.38M | Buy |
47,491
+7,201
| +18% | +$210K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $987K | Sell |
40,290
-915
| -2% | -$22.4K | ﹤0.01% | 2759 |
|
|
2022
Q2 | $171K | Sell |
41,205
-158,745
| -79% | -$659K | ﹤0.01% | 3162 |
|
|
2022
Q1 | $2.25M | Sell |
199,950
-2,428
| -1% | -$27.3K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $2.02M | Sell |
202,378
-11,604
| -5% | -$116K | ﹤0.01% | 2560 |
|
|
2021
Q3 | $2.79M | Sell |
213,982
-36,274
| -14% | -$474K | ﹤0.01% | 2520 |
|
|
2021
Q2 | $4.9M | Buy |
250,256
+96,987
| +63% | +$1.9M | ﹤0.01% | 2259 |
|
|
2021
Q1 | $3.26M | Buy |
153,269
+18,163
| +13% | +$386K | ﹤0.01% | 2378 |
|
|
2020
Q4 | $4.02M | Buy |
135,106
+15,447
| +13% | +$459K | ﹤0.01% | 2182 |
|
|
2020
Q3 | $2.59M | Buy |
119,659
+1,882
| +2% | +$40.8K | ﹤0.01% | 2255 |
|
|
2020
Q2 | $2.63M | Buy |
117,777
+11,181
| +10% | +$249K | ﹤0.01% | 2224 |
|
|
2020
Q1 | $1.62M | Buy |
106,596
+6,855
| +7% | +$104K | ﹤0.01% | 2286 |
|
|
2019
Q4 | $2.29M | Buy |
99,741
+26,025
| +35% | +$598K | ﹤0.01% | 2373 |
|
|
2019
Q3 | $1.59M | Sell |
73,716
-3,469
| -4% | -$74.9K | ﹤0.01% | 2505 |
|
|
2019
Q2 | $1.7M | Buy |
+77,185
| New | +$1.7M | ﹤0.01% | 2509 |
|